{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:14:49Z","timestamp":1788243289850,"version":"build-2803163510"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>\n                    Sarcopenia is increasingly recognized as a complication of type 2 diabetes mellitus (T2DM); however, simple screening tools for hospitalized older adults remain limited. The sarcopenia index (SI), calculated as serum creatinine (mg\/dL)\/cystatin C (mg\/L) \u00d7 100, has been proposed as a readily available biomarker of muscle mass. However, its clinical utility and optimal cut-off value in older Chinese inpatients with T2DM are unclear. This retrospective study included 296 hospitalized older patients with T2DM from the Department of Geriatrics at Shanghai Sixth People\u2019s Hospital between July 2019 and April 2020 and evaluated all-cause mortality. Sarcopenia risk was diagnosed according to the Asian Working Group for Sarcopenia 2019 consensus criteria. Logistic regression was performed to assess the association between SI and sarcopenia risk. Receiver operating characteristic (ROC) curve analysis was used to determine the optimal cut-off value, and Cox regression was used to evaluate the association between SI and mortality during follow-up (median 212 days). SI was significantly lower in patients with sarcopenia risk than in those without sarcopenia risk (68.0 \u00b1 21.6 vs. 77.4 \u00b1 20.0,\n                    <jats:italic>P<\/jats:italic>\n                    = 0.006). After adjusting for potential confounders, each 1-SD increase in SI was associated with a 68% lower risk of sarcopenia (adjusted OR = 0.32, 95% CI: 0.15\u20130.69). The optimal SI cutoff for detecting sarcopenia risk was 77.3 (AUC = 0.68, 95% CI: 0.59\u20130.77). Higher SI corresponded to a reduced risk of all-cause mortality during follow-up (median 212 days). after adjusting for potential confounders (HR per 1-SD = 0.70, 95% CI: 0.48\u20130.97). Subgroup analyses further revealed that the discriminative ability of SI varied by renal function, underscoring the necessity of kidney-specific validation. These findings suggest that SI is independently associated with sarcopenia risk and mortality in hospitalized older Chinese patients with T2DM and may provide a simple, low-cost tool for early sarcopenia screening in this high-risk population.\n                  <\/jats:p>","DOI":"10.3389\/fendo.2026.1940459","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:33:10Z","timestamp":1788240790000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Sarcopenia index (serum creatinine\/cystatin C ratio) independently identifies sarcopenia risk and mortality in older hospitalized patients with type 2 diabetes mellitus: a retrospective analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Tingting","family":"Lv","sequence":"first","affiliation":[{"name":"Department of Clinical Nutrition, Shanghai Sixth People\u2019s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]},{"name":"Department of Clinical Nutrition, College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Clinical Nutrition, Shanghai Sixth People\u2019s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]},{"name":"Department of Clinical Nutrition, College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiehua","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Gerontology, Shanghai Sixth People\u2019s Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingjun","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Gerontology, Shanghai Sixth People\u2019s Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehua","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Clinical Nutrition, Shanghai Sixth People\u2019s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]},{"name":"Department of Clinical Nutrition, College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Clinical Nutrition, Shanghai Sixth People\u2019s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]},{"name":"Department of Clinical Nutrition, College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Clinical Nutrition, Shanghai Sixth People\u2019s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]},{"name":"Department of Clinical Nutrition, College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised european consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"B2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/jcsm.12783","article-title":"Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis","volume":"13","author":"Petermann-Rocha","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.782391","article-title":"The association between diabetes mellitus and risk of sarcopenia: accumulated evidences from observational studies","volume":"12","author":"Qiao","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab884","article-title":"Prevalence and risk factors of sarcopenia in patients with diabetes: a meta-analysis","volume":"107","author":"Feng","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155585","article-title":"Diet, exercise, and pharmacotherapy for sarcopenia in people with diabetes","volume":"144","author":"Hashimoto","year":"2023","journal-title":"Metab Clin Exp"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-018-4185-y","article-title":"Validation of standardized creatinine and cystatin c gfr estimating equations in a large multicentre european cohort of children","volume":"34","author":"Bj Rk","year":"2019","journal-title":"Pediatr Nephrol (Berlin Germany)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.729","article-title":"Assessment of glomerular filtration rate in health and disease: a state of the art review","volume":"102","author":"Levey","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"B8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejim.2019.10.025","article-title":"Creatinine: from physiology to clinical application","volume":"72","author":"Kashani","year":"2020","journal-title":"Eur J Intern Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.34487","article-title":"Serum cystatin c is superior to serum creatinine as a marker of kidney function: a meta-analysis","volume":"40","author":"Dharnidharka","year":"2002","journal-title":"Am J Kidney Dis Off J Natl Kidney Foundation"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2018.05.031","article-title":"Validation of the sarcopenia index to assess muscle mass in the critically ill: a novel application of kidney function markers","volume":"38","author":"Barreto","year":"2019","journal-title":"Clin Nutr (Edinburgh Scotland)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(14)70034-8","article-title":"Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases","volume":"2","author":"Kalyani","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/s41598-020-58304-z","article-title":"Sarcopenia index based on serum creatinine and cystatin c is associated with 3-year mortality in hospitalized older patients","volume":"10","author":"Tang","year":"2020","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the national cholesterol education program (ncep) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-025-01004-y","article-title":"A focus shift from sarcopenia to muscle health in the asian working group for sarcopenia 2025 consensus update","volume":"5","author":"Chen","year":"2025","journal-title":"Nat Aging"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S013","article-title":"13. Older adults: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S186600","article-title":"Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship","volume":"12","author":"Mesinovic","year":"2019","journal-title":"Diabetes Metab Syndrome Obes Targets Ther"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-2537","article-title":"Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study","volume":"30","author":"Park","year":"2007","journal-title":"Diabetes Care"},{"key":"B18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5694\/mja16.01243","article-title":"Sarcopenia: a potential cause and consequence of type 2 diabetes in Australia's ageing population","volume":"207","author":"Scott","year":"2017","journal-title":"Med J Aust"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-15-0533","article-title":"Insulin resistance and sarcopenia: mechanistic links between common co-morbidities","volume":"229","author":"Cleasby","year":"2016","journal-title":"J Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2016.40.2.140","article-title":"Hyperglycemia is associated with impaired muscle quality in older men with diabetes: the korean longitudinal study on health and aging","volume":"40","author":"Yoon","year":"2016","journal-title":"Diabetes Metab J"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2019.110801","article-title":"Prevalence of sarcopenia as a comorbid disease: a systematic review and meta-analysis","volume":"131","author":"Pacifico","year":"2020","journal-title":"Exp Gerontol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jamda.2018.09.012","article-title":"Prevalence and associated factors of sarcopenia in nursing home residents: a systematic review and meta-analysis","volume":"20","author":"Shen","year":"2019","journal-title":"J Am Med Dir Assoc"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2023.105207","article-title":"Comparison of the serum creatinine- and cystatin-c-based indices as screening biomarkers for sarcopenia in community-dwelling older adults","volume":"115","author":"Jang","year":"2023","journal-title":"Arch Gerontol Geriatr"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glab369","article-title":"Creatinine to cystatin c ratio, a biomarker of sarcopenia measures and falls risk in community-dwelling older women","volume":"77","author":"Sim","year":"2022","journal-title":"Journals Gerontology Ser A Biol Sci Med Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.02.025","article-title":"Decreased the creatinine to cystatin c ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes","volume":"139","author":"Osaka","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1139\/apnm-2023-0476","article-title":"Association between macro- and microvascular damage and sarcopenia index in individuals with type 2 diabetes mellitus","volume":"49","author":"Xu","year":"2024","journal-title":"Appl Physiology Nutrition Metab = Physiologie Appliquee Nutr Metabolisme"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment","volume":"21","author":"Chen","year":"2020","journal-title":"J Am Med Dir Assoc"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2000.tb04694.x","article-title":"Skeletal muscle mass and muscle strength in relation to lower-extremity performance in older men and women","volume":"48","author":"Visser","year":"2000","journal-title":"J Am Geriatr Soc"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1940459\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:33:11Z","timestamp":1788240791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1940459\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":28,"alternative-id":["10.3389\/fendo.2026.1940459"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1940459","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"article-number":"1940459"}}